Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
SeraCare Life Sciences has launched three seroconversion panels that provide difficult-to-find patient samples for hepatitis B and HIV. HBV seroconversion panel PHM938 comprises six undiluted plasma samples from a single donor drawn over a six-day period and is HBV DNA-positive from the first bleed.
Randox Toxicology offers three new ELISA testing kits for the detection of sedative drugs zopiclone, zaleplon, and zolpidem, which behave similarly to benzodiazepines. Randox developed the ELISA kits for the detection of these drugs in urine and blood specimens. The zolpidem ELISA offers a limit of detection of 0.4 ng/mL in urine and 0.52 ng/mL in blood.
Dako has received FDA clearance to sell its Flex monoclonal rabbit anti-human estrogen receptor alpha, clone EP1 in the United States. The clone has been available in Europe for some time. With this diagnostic tool, breast cancer patients can be confident they are receiving effective treatment for their particular type of breast cancer.
Carl Zeiss Microscopy’s Axio Lab.A1 microscope is available for use in polarization microscopy. It is suitable for student education and routine laboratory requirements. This upright microscope suits colleges and universities, research institutes in the geosciences and mineralogy fields, and in the oil exploration industry.
Hamilton Robotics’ PCR setup Starlet automated liquid-handling system can accommodate any DNA amplification reagent kit, from simple setups and small budgets to highly demanding workflows. The workstation is suitable for gene expression, genotyping, sequencing, or mutagenesis. It was developed for different PCR types, such as endpoint-, q-, multiplex, or linear PCR.
CellaVision and Beckman Coulter have added Europe, the Middle East, and Africa to their global distribution agreement. The agreement gives Beckman Coulter a nonexclusive right to sell CellaVision’s products in hematology laboratories worldwide, except in Canada and Japan. Beckman and CellaVision have been developing their partnership since 2010, when they partnered in the United States, Latin America, and Asia-Pacific, including in China and India.
Thermo Fisher Scientific’s iCAP 7000 series ICP-OES (inductively coupled plasma optical emission spectrometer) is driven by Qtegra Intelligent Scientific Data Solution (ISDS) software. The platform, designed to streamline workflows and minimize cost per sample, facilitates trace elemental analysis in pharmaceutical, environmental, industrial, and food and beverage analysis applications.
Hardy Diagnostics’ parasite suspensions are designed for a variety of parasitology applications to provide reliable and consistent quality control results. The suspensions are microorganism preparations designed to mimic patient samples to support quality assurance programs in documenting process and detection proficiency. The suspensions can be used in the QC or validation of diagnostic test kits and methods, in microscopic examinations, in staining procedures, in proficiency testing, and for teaching purposes in educational settings.
Abbott has introduced in the European Union and other areas outside of the United States a molecular diagnostic test for the detection of influenza A/B and RSV (respiratory syncytial virus). The IMDx flu A/B and RSV assay, developed by Intelligent Medical Devices for Abbott’s m2000 molecular diagnostics analyzer, is performed on nasal and nasopharyngeal swabs from patients with signs and symptoms of respiratory infection. It is a qualitative, reverse-transcription polymerase chain reaction test for rapid detection of influenza A/B and RSV.
SciGene and BioDot have entered into an agreement whereby BioDot would have exclusive rights to market and sell SciGene’s Little Dipper Processor for fluorescence in situ hybridization to cytogenetic labs worldwide. The instrument automates tissue and cell sample processing for a variety of cytogenetic tests. Terms of the deal were not disclosed.
